On Tuesday, Uber Technologies, Inc.'s (NYSE:UBER) Uber Health collaborated with Acadia Healthcare Company, Inc. (NASDAQ:ACHC) to improve access to life-saving behavioral health care and addiction treatment.

The companies will initially focus on Acadia's national Comprehensive Treatment Centers (CTCs) network, which will provide medication-assisted treatment (MAT) in combination with counseling and behavioral therapies for those struggling with opioid addiction.

The collaboration will provide patients with transportation to begin treatment quickly and efficiently. Acadia and Uber Health plan to roll out the program to 19 facilities across several states.

Caitlin Donovan, Global Head of Uber Health, said, "Behavioral healthcare services are critical for many patients struggling with addiction; lack of transportation shouldn't stand in the way of accessing this support."

"By joining forces with Uber Health, Acadia Healthcare can quickly and easily connect patients with transportation to get the care they need, when they need it—and ultimately help improve patient outcomes at scale."

Dr. Nasser Khan, Group President, Acadia Healthcare CTC, said, "Working with Uber Health allows Acadia to eliminate this barrier and, in turn, shorten the length of time patients need to wait to begin life-saving treatment. In addition, the collaboration removes financial barriers to transportation access which can be a major roadblock to success in treatment."

Investors can gain exposure to the stock via IShares Trust IShares U.S. Transportation ETF (BATS:IYT) and Direxion Daily Transportation Bull 3X Shares (NYSE:TPOR).

Also Read: Uber Shifts Gears Down Under: Reportedly Lands $178M Settlement with Australian Taxi Drivers

Price Action: UBER shares are up 1.69% at $78.28 on the last check Wednesday.

Photo via Shutterstock